Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
about
Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological EvidenceVitamin D and Immune Response: Implications for Prostate Cancer in African AmericansRisk factors and biomarkers of life-threatening cancersLifestyle and dietary factors in the prevention of lethal prostate cancerCirculating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysisVitamin D deficiency predicts prostate biopsy outcomes.Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.Vitamin D supplements and cancer incidence and mortality: a meta-analysis.Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and gradeThe Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation.Consumption of fish products across the lifespan and prostate cancer riskThe association between pre-treatment serum 25-hydroxyvitamin D and survival in newly diagnosed stage IV prostate cancer.Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study.The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer.Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control studyVitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white AmericansmicroRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden.Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites.Nutrition and physical activity guidelines for cancer survivors.Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges.Vitamin D, PTH, and calcium in relation to survival following prostate cancer.Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience.Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment study.Can vitamin D supplementation reduce prostate cancer disparities?Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies.Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case-control study.Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis
P2860
Q26766256-08EC5C39-EF24-4494-95FC-28F71FC0C23DQ26768536-EF21A05E-B4C2-4124-A102-60524C229D63Q26774591-0329C301-E40B-4C88-A574-9F970CF161AAQ27025735-7DBB2A14-B0D5-4821-B579-C27C04FFFD66Q27336054-226AF81B-0958-491C-AEEE-295368974AB8Q33577607-A55A42B0-B12A-4A85-9EC1-DEF79A183B1FQ33923335-3048581C-6750-4B19-9BC4-7F71C7283C92Q33992150-8FFF9D05-6719-481B-9F58-64D75878A1D6Q34113467-4739FC0F-7D52-489D-B7E0-9313DC8D2195Q34228158-D51F346E-207C-459B-9DEF-86F4BDA83874Q34383359-782B17B6-47F4-4734-9482-813B06E3D330Q34683616-1EF08EC8-0110-48D8-B655-DAD6DC1AB713Q35182320-3B6A2CFB-017A-4AD4-BFDE-62BA8F733DAAQ35681151-C7EA25F5-B64D-4541-8A85-67DF248EBB12Q35878551-1ACA5708-29AC-486C-A9F3-670EE4E5562CQ35925515-0652FC6D-A811-4604-AC6B-D308D9E5DA94Q36069763-546EECE8-2C85-4F0E-A255-9B52529DFB8DQ36187658-468C959C-7AAC-42F1-90EF-7C5627E4D51BQ36250216-588CC2D5-F3F3-498A-AA5D-24F1E68B4FA9Q36378954-01539FEC-0177-4AEB-9BEA-391FE11A160DQ36379958-419D2974-026C-4281-B54B-14A631FE3879Q36468811-4ACFC933-7F0E-4593-A4C2-D070873806D8Q36514160-954F73FF-9D33-43CE-8E2E-3F1DAB692214Q36941178-6C94B01E-B5B7-4D9E-A983-B89A4BDAFCEBQ38005959-D60BCE80-4B97-4DB6-97AA-DD008403FD45Q38795645-87E42AC3-12A5-4957-8FC8-D22BF4383E21Q40829133-1E8E624A-2710-4C31-910F-4B2522111288Q43520763-1CB4AF2F-0F2A-4A79-83F2-A75A5D4C2A1BQ43731048-5C2B6738-B325-475D-A424-820AB5B23A21Q46658342-FFDA57ED-ABD7-4AC2-BE2F-DBCEFABDC101Q49540308-541A47B7-8E02-4F17-AB59-BCACD42168D2Q51514065-8F6418AF-3683-439E-9E90-6605197B83DBQ53294315-F01C445B-3158-4658-9574-9C65F6DFD1E4Q57818885-57AAEEB3-042E-4EFA-BCF0-6242B18B2022
P2860
Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prediagnostic plasma vitamin D ...... patients with prostate cancer.
@ast
Prediagnostic plasma vitamin D ...... patients with prostate cancer.
@en
type
label
Prediagnostic plasma vitamin D ...... patients with prostate cancer.
@ast
Prediagnostic plasma vitamin D ...... patients with prostate cancer.
@en
prefLabel
Prediagnostic plasma vitamin D ...... patients with prostate cancer.
@ast
Prediagnostic plasma vitamin D ...... patients with prostate cancer.
@en
P2093
P2860
P50
P1433
P1476
Prediagnostic plasma vitamin D ...... patients with prostate cancer.
@en
P2093
Bruce W Hollis
Irene Shui
J Michael Gaziano
Julie L Kasperzyk
Whitney Hendrickson
P2860
P304
P356
10.1371/JOURNAL.PONE.0018625
P407
P577
2011-04-06T00:00:00Z